SCYNEXIS Stock (NASDAQ: SCYX) stock price, news, charts, stock research, profile.
Open | $2.14 |
Close | $2.13 |
Volume / Avg. | 135.57K / 222.76K |
Day Range | 1.98 - 2.16 |
52 Wk Range | 1.35 - 3.87 |
Market Cap | $80.85M |
P/E Ratio | 1.01 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 53 |
Short Interest | 4.06% |
Days to Cover | 8 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of SCYNEXIS (NASDAQ:SCYX) through any online brokerage.
Other companies in SCYNEXIS’s space includes: CalciMedica (NASDAQ:CALC), Ocuphire Pharma (NASDAQ:OCUP), Rani Therapeutics Hldgs (NASDAQ:RANI), Marinus Pharma (NASDAQ:MRNS) and Qilian Intl Hldg Gr (NASDAQ:QLI).
There is no analysis for SCYNEXIS.
SCYNEXIS has a consensus price target of $10.00.
The stock price for SCYNEXIS (NASDAQ: SCYX) is $2.14 last updated July 22, 2024 at 8:34 AM EDT.
There are no upcoming dividends for SCYNEXIS.
SCYNEXIS’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for SCYNEXIS.
SCYNEXIS is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.